Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,099 public trials 2,041 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Study of CD137 Agonist ADG106 With Advanced or Metastatic Solid Tumors and/or Non-Hodgkin Lymphoma

NCT03707093

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Horizon Oncology Research Lafayette, Indiana, United States

NEXT Oncology San Antonio, Texas, United States

View Trial Details

Completed

Phase 1 Trial of CXD101 in Patients With Advanced Cancer

NCT01977638

Conditions: Advanced Cancer, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: Oxford University Hospitals NHS Trust Oxford, Oxfordshire, United Kingdom

View Trial Details

Completed

"Geriatric Assessment Adapted" Therapy for Ph- ALL Elderly Patients

NCT00475280

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: U.O. di Oncoematologia -plesso ospedaliero "A. Tortora" di Pagani Pagani, (SA), Italy

Nuovo Ospedale "Torrete" Ancona, Italy

USL 8 - Ospedale S.Donato Arezzo, Italy

Az. Ospedaliera S. G. Moscati Avellino, Italy

View all 32 locations

View Trial Details

Completed

EPOCH-R Chemotherapy Plus Bortezomib to Treat Mantle Cell Lymphoma

NCT00114738

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

A Clinical Trial of Buparlisib and Ibrutinib in Lymphoma

NCT02756247

Conditions: Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +13 more
Locations: Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States

Memorial Sloan Kettering Commack Commack, New York, United States

Memorial Sloan Kettering Westchester Harrison, New York, United States

View Trial Details

Completed

Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma

NCT01775475

Conditions: AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +17 more
Locations: Moi Teaching and Referral Hospital Eldoret, Kenya

University of Zimbabwe College of Health Sciences Harare, Zimbabwe

View Trial Details

Completed

Stepping Up: A Trial of Activity Monitoring Devices in Patients Undergoing Autologous Stem Cell Transplant

NCT04985409

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Cedars-Sinai Medical Center Los Angeles, California, United States

View Trial Details

Completed

Concealed Penis in Pediatric Age Group

NCT05565040

Conditions: Degloving Injuries, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +18 more
Locations: Faulty of Medicine Alexandria, Egypt

View Trial Details

Completed

A Study of Ibrutinib in the Treatment of Chronic Lymphocytic Leukemia and Mantle-cell Lymphoma in Routine Clinical Practice

NCT03425591

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +16 more
Locations: Paris, France

View Trial Details

Completed

Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas

NCT01030900

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions